In last trading session, Vivos Therapeutics Inc (NASDAQ:VVOS) saw 0.13 million shares changing hands with its beta currently measuring 7.67. Company’s recent per share price level of $3.40 trading at -$0.12 or -3.41% at ring of the bell on the day assigns it a market valuation of $16.44M. That closing price of VVOS’s stock is at a discount of -1335.0% from its 52-week high price of $48.79 and is indicating a premium of 43.82% from its 52-week low price of $1.91. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.2 million shares which gives us an average trading volume of 1.36 million if we extend that period to 3-months.
Vivos Therapeutics Inc (NASDAQ:VVOS) trade information
Upright in the red during last session for losing -3.41%, in the last five days VVOS remained trading in the green while hitting it’s week-highest on Tuesday, 11/26/24 when the stock touched $3.40 price level, adding 6.59% to its value on the day. Vivos Therapeutics Inc’s shares saw a change of -72.67% in year-to-date performance and have moved 17.65% in past 5-day. Vivos Therapeutics Inc (NASDAQ:VVOS) showed a performance of 17.24% in past 30-days. Number of shares sold short was 95088.0 shares which calculate 0.66 days to cover the short interests.
Vivos Therapeutics Inc (VVOS) estimates and forecasts
Statistics highlight that Vivos Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 74.36% of value to its shares in past 6 months, showing an annual growth rate of 75.98% while that of industry is 17.00. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 10.15% from the last financial year’s standing.
2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 3.89M for the same. And 1 analysts are in estimates of company making revenue of 4.1M in the next quarter. Company posted 3.25M and 3.42M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 3.00% during past 5 years.
Vivos Therapeutics Inc (NASDAQ:VVOS)’s Major holders
Insiders are in possession of 1.51% of company’s total shares while institution are holding 13.72 percent of that, with stock having share float percentage of 13.93%. Investors also watch the number of corporate investors in a company very closely, which is 13.72% institutions for Vivos Therapeutics Inc that are currently holding shares of the company.
